The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
The search for structure-specific nucleic acid-interactive drugs: Effects of compound structure on RNA versus DNA interaction strength
Abstract
The RNA genomes of a number of pathogenic RNA viruses, such as HIV-1, have extensive folded conformations with imperfect A-form duplexes that are essential for virus function and could serve as targets for structure-specific antiviral drugs. As an initial step in the discovery of such drugs, the interactions with RNA of a wide variety of compounds, which are known to bind to DNA in the minor groove, by classical or by threading intercalation, have been evaluated by thermal melting and viscometric analyses. The corresponding sequence RNA and DNA polymers, poly(A).poly(U) and poly(dA).poly(dT), were used as test systems for analysis of RNA binding strength and selectivity. Compounds that bind exclusively in the minor groove in AT sequences of DNA (e.g., netropsin, distamycin, and a zinc porphyrin derivative) do not have significant interactions with RNA. Compounds that bind in the minor grove in AT sequences of DNA but have other favorable interactions in GC sequences of DNA (e.q., Hoechst 33258, DAPI, and other aromatic diamidines) can have very strong RNA interactions. A group of classical intercalators and a group of intercalators with unfused aromatic ring systems contain compounds that intercalate and have strong interactions with RNA. At this time, no clear pattern of molecular structure that favors RNA over DNA interactions for intercalators has emerged. Compounds that bind to DNA by threading intercalation generally bind to RNA by the same mode, but none of the threading intercalators tested to date have shown selective interactions with RNA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Human Immunodeficiency Virus: Infectivity and Mechanisms of Pathogenesis
Fauci, A. S. (1988) · Science · doi:10.1126/science.3277274 · Cited by 1,486
The molecular origin of DNA-drug specificity in netropsin and distamycin.
Kopka, M. L., Yoon, C. N., Goodsell, D. S., et al. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.5.1376 · Cited by 817
Zimmer, C., & Wähnert, U. (1986) · Progress in Biophysics and Molecular Biology · doi:10.1016/0079-6107(86)90005-2 · Cited by 764
Molecular Targets for AIDS Therapy
Mitsuya, H., Yarchoan, R., & Broder, S. (1990) · Science · doi:10.1126/science.1699273 · Cited by 732
Coll, M., Frederick, C. A., Wang, A. H., & Rich, A. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.23.8385 · Cited by 684
HIV-1 tat trans-activation requires the loop sequence within tar
Feng, S., & Holland, E. C. (1988) · Nature · doi:10.1038/334165a0 · Cited by 549
Nucleic acids in chemistry and biology
Blackburn, G. M., Egli, M., Gait, M. J., & Watts, J. K. (1992) · International Journal of Biochemistry · doi:10.1016/0020-711x(92)90049-7 · Cited by 465
Fragments of the HIV-1 Tat Protein Specifically Biand TAR RNA
Weeks, K. M., Ampe, C., Schultz, S. C., Steitz, T. A., & Crothers, D. M. (1990) · Science · doi:10.1126/science.2205002 · Cited by 444
Binding of an antitumor drug to DNA
Kopka, M. L., Yoon, C., Goodsell, D. S., Pjura, P. E., & Dickerson, R. E. (1985) · Journal of Molecular Biology · doi:10.1016/0022-2836(85)90171-8 · Cited by 426
Molecular electrostatic potential of the nucleic acids
Pullman, A., & Pullman, B. (1981) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583500002341 · Cited by 411
HIV-1 rev regulation involves recognition of non-Watson-Crick base pairs in viral RNA
Bartel, D. P., Zapp, M. L., Green, M. R., & Szostak, J. W. (1991) · Cell · doi:10.1016/0092-8674(91)90527-6 · Cited by 378
Structures for the polynucleotide complexes Poly(dA)·Poly(dT) and Poly (dT)·Poly(dA)·Poly(dT)
(1975) · Journal of Molecular Biology · doi:10.1016/0022-2836(75)90194-1 · Cited by 367
Selby, M. J., Bain, E. S., Luciw, P. A., & Peterlin, B. M. (1989) · Genes & Development · doi:10.1101/gad.3.4.547 · Cited by 347
Molecular Aspects of Anticancer Drug-DNA Interactions
(1994) · doi:10.1007/978-1-349-13330-7 · Cited by 345
Vaishnav, Y. N., & Wong-Staal, F. (1991) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.60.070191.003045 · Cited by 325
RNA recognition by Tat-derived peptides: Interaction in the major groove?
Weeks, K. M., & Crothers, D. M. (1991) · Cell · doi:10.1016/0092-8674(81)90020-9 · Cited by 320
Loontiens, F. G., Regenfuss, P., Zechel, A., Dumortier, L., & Clegg, R. M. (1990) · Biochemistry · doi:10.1021/bi00490a021 · Cited by 308
Concepts in Viral Pathogenesis
(1984) · Springer eBooks · doi:10.1007/978-1-4612-5250-4 · Cited by 272
Hauber, J., & Cullen, B. R. (1988) · Journal of Virology · doi:10.1128/jvi.62.3.673-679.1988 · Cited by 236
Binding modes of distamycin A with d(CGCAAATTTGCG)2 determined by two-dimensional NMR
Pelton, J. G., & Wemmer, D. E. (1990) · Journal of the American Chemical Society · doi:10.1021/ja00160a016 · Cited by 219
Tris(tetramethylphenanthroline)ruthenium(II): a chiral probe that cleaves A-DNA conformations.
Mei, H. Y., & Barton, J. K. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.5.1339 · Cited by 179
Crystal structure of a pentamidine-oligonucleotide complex: implications for DNA-binding properties
Edwards, K. J., Jenkins, T. C., & Neidle, S. (1992) · Biochemistry · doi:10.1021/bi00146a011 · Cited by 175
Synthesis and antiprotozoal activity of 2,5-bis(4-guanylphenyl)furans
Das, B. P., & Boykin, D. W. (1977) · Journal of Medicinal Chemistry · doi:10.1021/jm00214a014 · Cited by 141
Self-citationGuntaka, R. V., Mahy, B. W. J., Bishop, J. M., & VARMUS, H. E. (1975) · Nature · doi:10.1038/253507a0 · Cited by 128
Ahmed, Y. F., Hanly, S. M., Malim, M. H., Cullen, B. R., & Greene, W. C. (1990) · Genes & Development · doi:10.1101/gad.4.6.1014 · Cited by 115
Kibler-Herzog, L., Kell, B., Zon, G., Shinozuka, K., Mizan, S., & Wilson, W. D. (1990) · Nucleic Acids Research · doi:10.1093/nar/18.12.3545 · Cited by 77
Self-citationDayton, E. T., Konings, D. A. M., Powell, D. M., Shapiro, B. A., Butini, L., Maizel, J. V., & Dayton, A. I. (1992) · Journal of Virology · doi:10.1128/jvi.66.2.1139-1151.1992 · Cited by 65
Le, S., Chen, J.-H., Braun, M. J., Gonda, M. A., & Maizel, J. V. (1988) · Nucleic Acids Research · doi:10.1093/nar/16.11.5153 · Cited by 51
RNA binding by the tat and rev proteins of HIV-1
Karn, J., Dingwall, C., Finch, J. T., Heaphy, S., & Gait, M. J. (1991) · Biochimie · doi:10.1016/0300-9084(91)90068-c · Cited by 44
Sarih‐Cottin, L., Hevia-Campos, E., Tharaud, D., & Litvak, S. (1980) · FEBS Letters · doi:10.1016/0014-5793(80)80411-x · Cited by 7
Cited by
Targeting RNA with Small Molecules
Thomas, J. R., & Hergenrother, P. J. (2008) · Chemical Reviews · doi:10.1021/cr0681546 · Cited by 647
Fang, M. Y., Markmiller, S., Vu, A. Q., Javaherian, A., Dowdle, W. E., Jolivet, P., Bushway, P. J., Castello, N. A., Baral, A., Chan, M. Y., et al. (2019) · Neuron · doi:10.1016/j.neuron.2019.05.048 · Cited by 282
Triple helix formation and the antigene strategy for sequence-specific control of gene expression
Praseuth, D., Guieysse, A. L., & Hélène, C. (1999) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(99)00149-9 · Cited by 262
Metadata
- Authors
- Wilson, W. D., Ratmeyer, L., Zhao, M., Strekowski, L., & Boykin, D.
- Venue
- Biochemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 1993-04-20
- Volume
- 32
- Issue
- 15
- Pages
- 4098-4104
- ISSN
- 0006-2960 (ISSN-L)
- 1520-4995
- OpenAlex
- W2074635589
- Cited by
- 408
- References
- 30
- FWCI
- 2.75
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
